Concepedia

Publication | Open Access

The Effect of Tiotropium in Symptomatic Asthma Despite Low- to Medium-Dose Inhaled Corticosteroids: A Randomized Controlled Trial

DOIFull Paper Access

95

Citations

16

References

2015

Year

Pierluigi Paggiaro, David Halpin, Roland Buhl, Michael E. Engel, Valentina Bayer Zubek, Zuzana Blahova, Petra Moroni-Zentgraf, Emílio Pizzichini
The Journal of Allergy and Clinical Immunology In Practice

Abstract

Once-daily tiotropium Respimat add-on therapy to low- to medium-dose ICS in adults with symptomatic asthma is an efficacious bronchodilator, and its safety and tolerability are comparable with those of placebo Respimat.

References

YearCitations

Page 1